Cargando…

Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study

BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapley, Jeffrey L., McGwin, Gerald, Ashraf, Ambika P., MacLennan, Paul A., Callahan, Koula, Searcey, Karen, Witherspoon, C. Douglas, Saaddine, Jinan, Owsley, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487844/
https://www.ncbi.nlm.nih.gov/pubmed/26136849
http://dx.doi.org/10.1186/s13098-015-0054-z
_version_ 1782379050374791168
author Tapley, Jeffrey L.
McGwin, Gerald
Ashraf, Ambika P.
MacLennan, Paul A.
Callahan, Koula
Searcey, Karen
Witherspoon, C. Douglas
Saaddine, Jinan
Owsley, Cynthia
author_facet Tapley, Jeffrey L.
McGwin, Gerald
Ashraf, Ambika P.
MacLennan, Paul A.
Callahan, Koula
Searcey, Karen
Witherspoon, C. Douglas
Saaddine, Jinan
Owsley, Cynthia
author_sort Tapley, Jeffrey L.
collection PubMed
description BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS: 236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history. RESULTS: Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired. CONCLUSIONS: Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high.
format Online
Article
Text
id pubmed-4487844
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44878442015-07-02 Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study Tapley, Jeffrey L. McGwin, Gerald Ashraf, Ambika P. MacLennan, Paul A. Callahan, Koula Searcey, Karen Witherspoon, C. Douglas Saaddine, Jinan Owsley, Cynthia Diabetol Metab Syndr Research BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS: 236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history. RESULTS: Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired. CONCLUSIONS: Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high. BioMed Central 2015-06-24 /pmc/articles/PMC4487844/ /pubmed/26136849 http://dx.doi.org/10.1186/s13098-015-0054-z Text en © Tapley et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tapley, Jeffrey L.
McGwin, Gerald
Ashraf, Ambika P.
MacLennan, Paul A.
Callahan, Koula
Searcey, Karen
Witherspoon, C. Douglas
Saaddine, Jinan
Owsley, Cynthia
Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title_full Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title_fullStr Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title_full_unstemmed Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title_short Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
title_sort feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487844/
https://www.ncbi.nlm.nih.gov/pubmed/26136849
http://dx.doi.org/10.1186/s13098-015-0054-z
work_keys_str_mv AT tapleyjeffreyl feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT mcgwingerald feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT ashrafambikap feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT maclennanpaula feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT callahankoula feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT searceykaren feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT witherspooncdouglas feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT saaddinejinan feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy
AT owsleycynthia feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy